Coronavirus (COVID-19) update: FDA withdraws emergency approval for Bamlanivimab monoclonal antibody
For immediate release: 16 April 2021 Today, the US Food and Drug Administration revoked the emergency use authorization (EUA) that enabled the monoclonal antibody therapy bamlanivimab, when adminis…
